Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGXNASDAQ:EXASNASDAQ:GHNYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$179.74+0.2%$174.68$135.47▼$182.38$20.03B0.49992,562 shs1.20 million shsEXASExact Sciences$52.54-0.9%$52.04$39.97▼$72.83$10.00B0.982.57 million shs2.21 million shsGHGuardant Health$48.55-1.2%$44.52$20.14▼$52.92$6.09B1.382.14 million shs2.39 million shsLHLabcorp$261.01-0.3%$245.03$198.96▼$264.03$21.92B0.81635,343 shs747,211 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics+0.24%-1.28%+4.90%+8.61%+29.35%EXASExact Sciences-0.91%-1.43%-7.74%+15.04%+17.15%GHGuardant Health-1.20%-1.52%+27.76%+4.50%+64.24%LHLabcorp-0.39%-1.11%+7.55%+11.76%+27.17%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.928 of 5 stars2.34.04.24.73.72.52.5EXASExact Sciences4.6887 of 5 stars4.53.00.04.72.32.50.6GHGuardant Health4.2496 of 5 stars3.53.00.04.31.92.50.6LHLabcorp4.487 of 5 stars2.43.02.54.23.32.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.69Moderate Buy$185.733.33% UpsideEXASExact Sciences 2.95Moderate Buy$70.9034.94% UpsideGHGuardant Health 3.00Buy$53.7610.74% UpsideLHLabcorp 2.86Moderate Buy$274.004.98% UpsideCurrent Analyst Ratings BreakdownLatest DGX, LH, EXAS, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/13/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.005/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/6/2025DGXQuest DiagnosticsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.005/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.005/2/2025EXASExact SciencesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$55.00 ➝ $75.005/2/2025EXASExact SciencesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$52.00 ➝ $54.005/2/2025EXASExact SciencesEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$60.00 ➝ $66.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B2.03$13.52 per share13.29$61.38 per share2.93EXASExact Sciences$2.76B3.59$5.58 per share9.41$12.98 per share4.05GHGuardant Health$739.02M8.14N/AN/A($1.13) per share-42.96LHLabcorp$13.01B1.68$22.33 per share11.69$96.27 per share2.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$7.9122.7217.132.508.81%15.11%6.65%7/22/2025 (Estimated)EXASExact Sciences-$1.03B-$5.51N/A105.0840.25-36.06%-3.75%-1.68%7/30/2025 (Estimated)GHGuardant Health-$436.37M-$3.39N/AN/AN/A-53.82%-1,200.44%-26.77%8/6/2025 (Estimated)LHLabcorp$746M$8.6530.1714.881.665.55%15.27%6.97%7/30/2025 (Estimated)Latest DGX, LH, EXAS, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025DGXQuest Diagnostics$2.56N/AN/AN/A$2.73 billionN/A5/1/2025Q1 2025EXASExact Sciences-$0.37-$0.21+$0.16-$0.54$688.58 million$706.79 million4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.78%N/A40.46%14 YearsEXASExact SciencesN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/ALHLabcorp$2.881.10%N/A33.29%N/ALatest DGX, LH, EXAS, and GH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20254/10/2025LHLabcorpquarterly$0.721.25%5/29/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.841.441.31EXASExact Sciences0.972.732.38GHGuardant HealthN/A4.113.76LHLabcorp0.681.841.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%EXASExact Sciences88.82%GHGuardant Health92.60%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%EXASExact Sciences1.20%GHGuardant Health6.10%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableEXASExact Sciences7,000188.64 million186.37 millionOptionableGHGuardant Health2,021123.89 million116.33 millionNot OptionableLHLabcorp70,00083.70 million83.00 millionOptionableDGX, LH, EXAS, and GH HeadlinesRecent News About These CompaniesWealth Enhancement Advisory Services LLC Has $8.42 Million Stock Holdings in Labcorp Holdings Inc. (NYSE:LH)June 24 at 3:24 AM | marketbeat.comLabcorp Holdings Inc.'s (NYSE:LH) Intrinsic Value Is Potentially 59% Above Its Share PriceJune 23 at 4:10 PM | uk.finance.yahoo.com5 Insightful Analyst Questions From Labcorp’s Q1 Earnings CallJune 23 at 11:09 AM | msn.comMarietta Wealth Management LLC Purchases 7,304 Shares of Labcorp Holdings Inc. (NYSE:LH)June 21 at 6:34 AM | marketbeat.comLabcorp Unveils Whole Health Solutions For Functional And Integrative Medicine ProvidersJune 20, 2025 | nasdaq.comIs Labcorp Holdings Stock Outperforming the Dow?June 20, 2025 | msn.comLabcorp Holdings Inc LHJune 19, 2025 | morningstar.com4,201 Shares in Labcorp Holdings Inc. (NYSE:LH) Acquired by Friedenthal FinancialJune 19, 2025 | marketbeat.comLabcorp Launches Labcorp Whole Health Solutions to Support Holistic CareJune 18, 2025 | finance.yahoo.comLabcorp Stock Climbs 25.6% This Year: What's Driving the Surge?June 18, 2025 | zacks.comPKO Investment Management Joint Stock Co Invests $233,000 in Labcorp Holdings Inc. (NYSE:LH)June 18, 2025 | marketbeat.comLabcorp Holdings Inc. stock underperforms Monday when compared to competitors despite daily gainsJune 18, 2025 | marketwatch.comLabcorp Holdings Inc. stock outperforms competitors despite losses on the dayJune 18, 2025 | marketwatch.comBirch Hill Investment Advisors LLC Has $33.43 Million Stock Position in Laboratory Co. of America Holdings (NYSE:LH)June 17, 2025 | marketbeat.comMn Services Vermogensbeheer B.V. Sells 2,400 Shares of Laboratory Co. of America Holdings (NYSE:LH)June 17, 2025 | marketbeat.comFarther Finance Advisors LLC Has $430,000 Stock Holdings in Laboratory Co. of America Holdings (NYSE:LH)June 17, 2025 | marketbeat.comLaboratory Co. of America (NYSE:LH) Sets New 52-Week High - Time to Buy?June 16, 2025 | marketbeat.comAzzad Asset Management Inc. ADV Makes New Investment in Laboratory Co. of America Holdings (NYSE:LH)June 16, 2025 | marketbeat.comBrokerages Set Laboratory Co. of America Holdings (NYSE:LH) PT at $274.00June 16, 2025 | americanbankingnews.comHandelsbanken Fonder AB Raises Stock Position in Laboratory Co. of America Holdings (NYSE:LH)June 14, 2025 | marketbeat.comSmithbridge Asset Management Inc. DE Acquires New Position in Laboratory Co. of America Holdings (NYSE:LH)June 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsDGX, LH, EXAS, and GH Company DescriptionsQuest Diagnostics NYSE:DGX$179.74 +0.31 (+0.17%) Closing price 06/23/2025 03:59 PM EasternExtended Trading$178.00 -1.74 (-0.97%) As of 06/23/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.Exact Sciences NASDAQ:EXAS$52.54 -0.48 (-0.91%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$52.31 -0.23 (-0.44%) As of 06/23/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.Guardant Health NASDAQ:GH$48.55 -0.59 (-1.20%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$49.06 +0.51 (+1.04%) As of 06/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Labcorp NYSE:LH$261.01 -0.87 (-0.33%) Closing price 06/23/2025 03:59 PM EasternExtended Trading$261.10 +0.10 (+0.04%) As of 06/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
